OBJECTIVE Diabetic cardiomyopathy is associated with increased mortality in patients with diabetes. The underlying pathology of this disease is still under discussion. We studied the role of the kinin B1 receptor on the development of experimental diabetic cardiomyopathy. RESEARCH DESIGN AND METHODS We utilized B1 receptor knockout mice and investigated cardiac inflammation, fibrosis, and oxi...

Diabetes effects start in utero and affect neonates, infants, children and adolescent. Gestational diabetes may have overwhelming effects on the embryonic heart as well as the infants born to diabetic mothers. The neonates and infants suffering this metabolic disease may have considerable cardiovascular effects [1]. Hypertrophic cardiomyopathy is a well known condition observed in infants of di...

People with DM can develop heart dysfunction called diabetic cardiomyopathy [5]. This is characterized by dilation and hypertrophy of the myocardium, accompanied by systolic dysfunction and / or left ventricular diastolic and their presence is independent of ischemic heart disease or hypertension coexistence [7]. Although diabetic cardiomyopathy is a chronic subclinical condition [8], eventuall...

Diabetic cardiomyopathy entails the cardiac injury induced by diabetes independently of any vascular disease or hypertension. Some transcription factors have been proposed to control the gene program involved in the setting and development of related processes. Nuclear factor-kappa B is a pleiotropic transcription factor associated to the regulation of many heart diseases. However, the nuclear ...

Diabetes mellitus has been shown to be associated with heart failure of unknown origin, which is termed ‘diabetic w x w x cardiomyopathy’ 1 . Regan et al. 2 have shown that the small vessel lesions in diabetes mellitus have little or no relation to diabetic cardiomyopathy, suggesting that the contractile function of the diabetic cardiomyopathy was primarily defective. Although many studies have...

Diabetes is a progressive metabolic disorder that can ultimately lead to serious chronic vascular complications including renal failure, vision loss, and cardiac dysfunction (Ruiz and Chakrabarti, 2013). Diabetic cardiomyopathy is responsible for higher incidence of sudden cardiac death and represents the leading cause of morbidity and mortality among the diabetic patients (Aksnes et al., 2007;...

Diabetic cardiomyopathy is associated with suppression of cardiac autophagy, and activation of AMP-activated protein kinase (AMPK) restores cardiac autophagy and prevents cardiomyopathy in diabetic mice, albeit by an unknown mechanism. We hypothesized that AMPK-induced autophagy ameliorates diabetic cardiomyopathy by inhibiting cardiomyocyte apoptosis and examined the effects of AMPK on the int...

Diabetic cardiomyopathy is defined as ventricular dysfunction initiated by alterations in cardiac energy substrates in the absence of coronary artery disease and hypertension. In addition to the demonstrated burden of cardiovascular events associated with diabetes, diabetic cardiomyopathy partly explains why diabetic patients are subject to a greater risk of heart failure and a worse outcome af...